USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ALPHACORE PHARMA, LLC
Address:
ALPHACORE PHARMA, LLC
2900 Huron Parkway, Suite 5
ANN ARBOR, MI
Phone:
N/A
URL:
N/A
EIN:
126038952
DUNS:
801351896
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $240,129.00 1
SBIR Phase II $1,254,300.00 1

Award List:

The Use of LCAT Infusion to Treat Acute Coronary Syndromes

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$240,129.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Coronary heart disease, the most prevalent manifestation of atherosclerosis, remains the single largest killer of American men and women. The hallmark of vascular disease or atherosclerosis is the accumulation of chol esterol in arteries, which can lead to… More

Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$1,254,300.00
Agency:
HHS
Principal Investigator:
Brian R. Krause
Abstract:
DESCRIPTION (provided by applicant): The hallmark of atherosclerosis is the accumulation of cholesterol in arteries, resulting in plaque which can lead to a heart attack (myocardial infarction (MI)). The excess cholesterol causes inflammation, promotes p laque instability, and in later stages,… More